Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading?

Rossella E Nappi,Lara Tiranini,Laura Cucinella,Ellis Martini,David Bosoni,Alessandra Righi,Chiara Cassani,Barbara Gardella

Expert opinion on pharmacotherapy（2023）

引用 3|浏览6

暂无评分

摘要

Approved pharmacotherapies for FSD are limited. Validated multidimensional instruments and adequate objective measures of physical and mental responses to sexual external and internal incentives are mandatory to identify women suitable to chronic or on-demand treatments and to assess their pattern of response in research and practice.

查看译文

关键词

Bremelanotide,dehydroepiandrosterone (DHEA),flibanserin,genitourinary syndrome of menopause (GSM),hypoactive sexual desire disorder (HSDD),local estrogen therapy (LET),ospemifene,psychoactive drugs,testosterone,vulvovaginal atrophy (VVA)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要